The 'cytokine storm': molecular mechanisms and therapeutic prospects
R Karki, TD Kanneganti - Trends in immunology, 2021 - cell.com
Cytokine storm syndrome (CSS) has generally been described as a collection of clinical
manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are …
manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are …
Anakinra therapy for non-cancer inflammatory diseases
G Cavalli, CA Dinarello - Frontiers in pharmacology, 2018 - frontiersin.org
Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1α and IL-
1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory …
1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory …
Treating inflammation by blocking interleukin-1 in humans
CA Dinarello, JWM van der Meer - Seminars in immunology, 2013 - Elsevier
IL-1 is a master cytokine of local and systemic inflammation. With the availability of specific
IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL …
IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL …
Neutrophilic dermatoses: pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease
CA Nelson, S Stephen, HJ Ashchyan… - Journal of the American …, 2018 - Elsevier
Neutrophilic dermatoses are a heterogeneous group of inflammatory skin disorders that
present with unique clinical features but are unified by the presence of a sterile …
present with unique clinical features but are unified by the presence of a sterile …
Insights into the pathogenesis of Sweet's syndrome
MS Heath, AG Ortega-Loayza - Frontiers in immunology, 2019 - frontiersin.org
Sweet's syndrome, also known as Acute Febrile Neutrophilic Dermatosis, is a rare
inflammatory condition. It is considered to be the prototype disease of neutrophilic …
inflammatory condition. It is considered to be the prototype disease of neutrophilic …
Infectious complications of biological and small molecule targeted immunomodulatory therapies
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …
immunosuppression. We have moved from relying on broadly active traditional medications …
Mechanisms of inflammation in neutrophil-mediated skin diseases
AV Marzano, AG Ortega-Loayza, M Heath… - Frontiers in …, 2019 - frontiersin.org
Neutrophil-mediated skin diseases, originally named neutrophilic dermatoses (NDs), are a
group of conditions due to an altered neutrophil recruitment and activation, characterized by …
group of conditions due to an altered neutrophil recruitment and activation, characterized by …
Therapeutic potential of targeting interleukin‐1 family cytokines in chronic inflammatory skin diseases
L Calabrese, Z Fiocco, TK Satoh… - British Journal of …, 2022 - academic.oup.com
Summary The interleukin (IL)‐1 family of cytokines is a central regulator of a myriad of
immunological responses. It comprises several cytokines, including those belonging to the …
immunological responses. It comprises several cytokines, including those belonging to the …
Sweet syndrome: a review and update
CD Villarreal-Villarreal, J Ocampo-Candiani… - Actas dermo …, 2016 - Elsevier
Sweet syndrome is the most representative entity of febrile neutrophilic dermatoses. It
typically presents in patients with pirexya, neutrophilia, painful tender erytomatous papules …
typically presents in patients with pirexya, neutrophilia, painful tender erytomatous papules …
Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients
NM Rochet, RN Chavan, MA Cappel, DA Wada… - Journal of the American …, 2013 - Elsevier
Background Sweet syndrome is a neutrophilic dermatosis with cutaneous tender lesions that
can be associated with malignancies, infections, systemic inflammatory disorders, and …
can be associated with malignancies, infections, systemic inflammatory disorders, and …